Shanghai Henlius Biotech, Inc. (HKG:2696)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
54.10
+0.85 (1.60%)
Jul 30, 2026, 4:08 PM HKT

Shanghai Henlius Biotech Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
827.04820.47546.02-695.26-984.05
Depreciation & Amortization
421.02367.24353.32273.12196.56
Other Amortization
8.397.565.914.4832.62
Loss (Gain) From Sale of Assets
-11.32-0.82-0.720.250.93
Stock-Based Compensation
124.52-2.5912.5248.42
Provision & Write-off of Bad Debts
10.57-5.039.031.640.17
Other Operating Activities
92.51109.11152.88284.19284.61
Change in Accounts Receivable
-942.48-165.95-283.77-161.41-99.7
Change in Inventory
92.3923.86-22.34-340.64-91.71
Change in Accounts Payable
212.5161.37-108.34312.5620.04
Change in Unearned Revenue
702.14120.24495.12227.14303.83
Change in Other Net Operating Assets
-231.68-196.15-101.781,063378.68
Operating Cash Flow
1,3061,2421,048981.6290.39
Operating Cash Flow Growth
5.13%18.51%6.75%985.96%-

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-311.37-164.01-473.67-584.97-460.43
Sale of Property, Plant & Equipment
0.170.240.026.560.55
Cash Acquisitions
---15--
Sale (Purchase) of Intangibles
-888.37-673.2-537.77-780.32-670.76
Investment in Securities
3.42-73-120--
Other Investing Activities
--141.98--550.61
Investing Cash Flow
-1,196-909.97-1,004-1,359-1,681

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
3,8762,6742,5122,8592,096
Total Debt Issued
3,8762,6742,5122,8592,096
Long-Term Debt Repaid
-3,866-3,184-2,237-1,886-1,364
Total Debt Repaid
-3,866-3,184-2,237-1,886-1,364
Net Debt Issued (Repaid)
9.13-510.34274.34972.77731.67
Other Financing Activities
-102.99-133.03-129.91-114.75-83.36
Financing Cash Flow
-93.86-643.37144.43858.02648.3

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-7.815.186.2737.59-16.77
Net Cash Flow
7.81-296.26194.19518.49-959.33

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
994.251,078574.25396.65-370.04
Free Cash Flow Growth
-7.76%87.70%44.77%--
Free Cash Flow Margin
14.91%18.83%10.64%12.34%-21.99%
Free Cash Flow Per Share
1.821.981.060.73-0.69
Levered Free Cash Flow
-922.42176.66-709.99-1,019-857.51
Unlevered Free Cash Flow
-858.37253.46-640.9-952.46-804.5

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
102.99133.03129.91114.7583.2
Cash Income Tax Paid
5.5628.2620.711.37-
Change in Working Capital
-167.11-56.64-21.111,101511.13